Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases
Sinan Lin, Ren Mao, Chenchen Qian, et al.
Physiological Reviews (2021) Vol. 102, Iss. 2, pp. 605-652
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Fibrosis in IBD: from pathogenesis to therapeutic targets
Florian Rieder, Pranab K. Mukherjee, William J. Massey, et al.
Gut (2024) Vol. 73, Iss. 5, pp. 854-866
Closed Access | Times Cited: 39
A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice
Dominik Bettenworth, Mark E. Baker, Joel G. Fletcher, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 8, pp. 572-584
Open Access | Times Cited: 15
Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis
Sinan Lin, Jie Wang, Pranab K. Mukherjee, et al.
Gut (2024) Vol. 73, Iss. 7, pp. 1110-1123
Open Access | Times Cited: 11
TWIST1+FAP+ fibroblasts in the pathogenesis of intestinal fibrosis in Crohn’s disease
Yao Zhang, Jiaxin Wang, Hongxiang Sun, et al.
Journal of Clinical Investigation (2024)
Open Access | Times Cited: 9
Recent advances in intestinal fibrosis
Marco Vincenzo Lenti, Giovanni Santacroce, Giacomo Broglio, et al.
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101251-101251
Closed Access | Times Cited: 8
AI-luminating Artificial Intelligence in Inflammatory Bowel Diseases: A Narrative Review on the Role of AI in Endoscopy, Histology, and Imaging for IBD
Phillip Gu, Oreen Mendonca, Dan Carter, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 12, pp. 2467-2485
Closed Access | Times Cited: 7
The current landscape of antifibrotic therapy across different organs: A systematic approach
Isabel Fuster‐Martínez, Sara Calatayud
Pharmacological Research (2024) Vol. 205, pp. 107245-107245
Open Access | Times Cited: 6
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease
Florian Rieder, Christopher Ma, Jurij Hanžel, et al.
Radiology (2024) Vol. 312, Iss. 2
Closed Access | Times Cited: 6
A practical guide to dilating inflammatory bowel disease strictures
Natasha Klemm, Joseph D. Feuerstein
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Mechanosensitive Ion Channel PIEZO1 as a Key Regulator of Intestinal Fibrosis in Crohn’s Disease
Luyao Zhang, Qiuyuan Liu, Xiaodong Yang, et al.
Inflammatory Bowel Diseases (2025)
Closed Access
Therapeutic modulation of the liver immune microenvironment
Herbert Tilg, Timon E. Adolph, Frank Tacke
Hepatology (2023)
Closed Access | Times Cited: 14
PPAR-Gamma Orchestrates EMT, AGE, and Cellular Senescence Pathways in Colonic Epithelium and Restrains the Progression of IBDs
Simona Pompili, Antonella Vetuschi, Giovanni Latella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8952-8952
Open Access | Times Cited: 14
Balloon-assisted enteroscopy-based endoscopic stricturotomy for deep small bowel strictures from Crohn's disease: First cohort study of a novel approach
Shou‐Bin Ning, Hongsheng Yang, Bai‐Rong Li, et al.
Digestive and Liver Disease (2023) Vol. 55, Iss. 10, pp. 1397-1402
Closed Access | Times Cited: 12
Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease
Ilaria Laudadio, Claudia Carissimi, Noemi Scafa, et al.
Inflammation Research (2024) Vol. 73, Iss. 8, pp. 1359-1370
Open Access | Times Cited: 4
Mucosa-Associated Oscillospira sp. Is Related to Intestinal Stricture and Post-Operative Disease Course in Crohn’s Disease
Shukai Zhan, Caiguang Liu, Jixin Meng, et al.
Microorganisms (2023) Vol. 11, Iss. 3, pp. 794-794
Open Access | Times Cited: 11
The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: A Descending Process or a Programmed Consequence?
Sara Jarmakiewicz-Czaja, Aneta Sokal, Katarzyna Ferenc, et al.
Genes (2023) Vol. 14, Iss. 6, pp. 1167-1167
Open Access | Times Cited: 10
How to Evaluate Fibrosis in IBD?
Helena Tavares de Sousa, Fernando Magro
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2188-2188
Open Access | Times Cited: 10
Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis
Kristina Koop, Karin Enderle, Miriam Hillmann, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
In-hospital management of inflammatory bowel disease
Jeffrey Berinstein, Daniel Aintabi, Peter Higgins
Current Opinion in Gastroenterology (2023) Vol. 39, Iss. 4, pp. 274-286
Closed Access | Times Cited: 8
Mesenteric adipose-derived exosomal TINAGL1 enhances intestinal fibrosis in Crohn's Disease via SMAD4
Yidong Chen, Junrong Li, Xiao‐Peng Zhang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Intestinal E. coli-produced yersiniabactin promotes profibrotic macrophages in Crohn’s disease
Ju-Hyun Ahn, Marlus da Silva Pedrosa, Lacey R. Lopez, et al.
Cell Host & Microbe (2024)
Open Access | Times Cited: 2
Prospective therapeutics for intestinal and hepatic fibrosis
Xin Li, Mengli Yu, Qingwei Zhao, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 7
Drug Repurposing in Crohn’s Disease Using Danish Real-World Data
Saeed Shakibfar, Kristine H. Allin, Tine Jess, et al.
Pragmatic and Observational Research (2024) Vol. Volume 15, pp. 17-29
Open Access | Times Cited: 2
Fibrostenosing Crohn’s Disease: Pathogenetic Mechanisms and New Therapeutic Horizons
Irene Mignini, Valentina Blasi, Fabrizio Termite, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6326-6326
Open Access | Times Cited: 2
Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-β1/Smad3 Signaling
Ying Wang, Zhi Wang, Huiping Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top